HAP Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,502
Closed -$438K 1165
2022
Q4
$438K Buy
15,502
+3,912
+34% +$124K 0.04% 308
2022
Q3
$381K Buy
+11,590
New +$425K 0.03% 413
2021
Q3
Sell
-24,585
Closed -$2.06M 2420
2021
Q2
$2.27M Buy
+24,585
New +$2.09M 0.07% 261
2020
Q1
Sell
-20,335
Closed -$682K 1203
2019
Q4
$682K Sell
20,335
-25,991
-56% -$826K 0.04% 257
2019
Q3
$1.37M Buy
+46,326
New +$1.51M 0.11% 157

Other funds holding ARKG

HAP Trading's ARKG Position: Q1 2023 in Review

HAP Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 15,502 shares — an estimated $438K sold.

HAP Trading first reported a position in ARKG in Q3 2019 and held it in 5 quarters. The position peaked at $2.27M in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • HAP Trading reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 15,502 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $438K.
  • HAP Trading first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 5 quarters.
  • HAP Trading's ARK Genomic Revolution ETF position peaked at $2.27M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.